Open Access

Pioglitazone protects PC12 cells against oxidative stress injury: An in vitro study of its antiapoptotic effects via the PPARγ pathway

  • Authors:
    • Yali Li
    • Jun Long
    • Libo Li
    • Ziyao Yu
    • Yanjing Liang
    • Bin Hou
    • Li Xiang
    • Xiaolin Niu
  • View Affiliations

  • Published online on: September 22, 2023     https://doi.org/10.3892/etm.2023.12221
  • Article Number: 522
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To the best of our knowledge, the role of peroxisome proliferator‑activated receptor γ (PPARγ) in oxidative stress‑induced PC12 cell damage is unknown. Using a PC12 cell model with H2O2 treatment, the present study investigated the expression levels of apoptosis‑related genes and neuronal apoptosis after oxidative stress injury. The present study further investigated the protective effect and mechanism of pioglitazone, a PPARγ agonist. PC12 cells treated with H2O2 were used as a model of oxidative stress injury. An MTT assay and flow cytometry were used to detect the effect of H2O2 on PC12 cell viability and the protective effect of pioglitazone. A TUNEL assay was used to detect neuronal apoptosis. The expression levels of PPARγ, Bax, Bcl‑2 and caspase‑3 were examined by reverse transcription‑quantitative PCR and western blotting. H2O2 reduced PC12 cell viability in a dose‑ and time‑dependent manner. H2O2 significantly upregulated the protein expression levels of Bax and the cleaved caspase‑3/caspase‑3 ratio (P<0.01), decreased the protein expression levels of Bcl‑2 (P<0.01), and increased the apoptosis rate of PC12 cells. Pioglitazone significantly reduced the protein expression levels of Bax and the cleaved caspase‑3/caspase‑3 ratio (P<0.01), increased the expression levels of Bcl‑2 (P<0.01), decreased the Bax/Bcl‑2 expression ratio (P<0.01) and increased the viability of H2O2‑damaged PC12 cells in a dose‑dependent manner. Treatment with the PPARγ antagonist GW9662 or PPARγ small interfering RNA counteracted the protective effect of pioglitazone on PC12 cells to different extents (P<0.01). Therefore, the present study reported the role of PPARγ in protecting PC12 cells against oxidative stress injury, which may lead to novel therapeutic approaches for neurodegenerative diseases.
View Figures
View References

Related Articles

Journal Cover

November-2023
Volume 26 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Long J, Li L, Yu Z, Liang Y, Hou B, Xiang L and Niu X: Pioglitazone protects PC12 cells against oxidative stress injury: An <em>in vitro</em> study of its antiapoptotic effects via the PPARγ pathway. Exp Ther Med 26: 522, 2023
APA
Li, Y., Long, J., Li, L., Yu, Z., Liang, Y., Hou, B. ... Niu, X. (2023). Pioglitazone protects PC12 cells against oxidative stress injury: An <em>in vitro</em> study of its antiapoptotic effects via the PPARγ pathway. Experimental and Therapeutic Medicine, 26, 522. https://doi.org/10.3892/etm.2023.12221
MLA
Li, Y., Long, J., Li, L., Yu, Z., Liang, Y., Hou, B., Xiang, L., Niu, X."Pioglitazone protects PC12 cells against oxidative stress injury: An <em>in vitro</em> study of its antiapoptotic effects via the PPARγ pathway". Experimental and Therapeutic Medicine 26.5 (2023): 522.
Chicago
Li, Y., Long, J., Li, L., Yu, Z., Liang, Y., Hou, B., Xiang, L., Niu, X."Pioglitazone protects PC12 cells against oxidative stress injury: An <em>in vitro</em> study of its antiapoptotic effects via the PPARγ pathway". Experimental and Therapeutic Medicine 26, no. 5 (2023): 522. https://doi.org/10.3892/etm.2023.12221